News Sentiment

GILD sentiment intelligence

Gilead Sciences, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 54 Balanced news tone 27 relevant articles
Exchange VIE Austria
Sector Healthcare Market context
Industry Drug Manufacturers - General Read-through group
Latest close 114.86 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

87/100 classification confidence.

Company focus 27

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+0.6% over one week, +6.2% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Gilead Sciences (GILD) CFO sells 3,000 shares in pre-set 10b5-1 plan

Market Reaction

Balanced read

55/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 87/100 classification
One-week reaction 0.6% Price digesting
Trend fit Trend inactive 6.2% over four weeks
Fair value 34.6% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 21
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 27
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 6
marketscreener.com 4
Stock Titan 3
TIKR.com 2
Investing.com 2
GuruFocus 1
24/7 Wall St. 1
StockStory 1

Event Lens

What the news is about

Classified themes
Market update 21
Earnings 2
Deals and strategy 2
Regulatory and legal 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-27 of 27